Month: July 2023

MONTVALE, N.J., July 14, 2023 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 28th at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Second quarter results will be published prior to the market opening on Friday, July 28, 2023. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion of the...

BOSTON, July 14, 2023 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced that it will release its second quarter 2023 results after the close of market trading on Thursday, August 3, 2023. DraftKings will host a conference call and audio webcast the following morning, Friday, August 4, 2023, at 8:30 a.m. ET, during which management will discuss the Company’s results and provide commentary on business performance. To listen to the audio webcast and live Q&A, please visit DraftKings’ investor relations website at investors.draftkings.com. The audio webcast will be available on the Company’s investor relations website until 11:59 p.m. ET on September 30, 2023. About DraftKingsDraftKings Inc. is a digital sports entertainment and gaming company created to fuel the competitive spirit...

WILMINGTON, Del., July 14, 2023 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) today announced plans to issue its fiscal-third quarter earnings release at approximately 5 p.m. ET on Tuesday, July 25, 2023. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, July 26, 2023. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Participants in the webcast presentation include:Guillermo Novo, chair, and chief executive officer Kevin Willis, senior vice president and chief financial officer and Seth Mrozek, director of investor relationsTo access the call by phone, please use this registration link to be provided with dial in details....

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, July 14, 2023 (GLOBE NEWSWIRE) — Halcones Precious Metals Corp. (TSXV: HPM) (the “Company” or “Halcones”) has closed the first tranche (the “First Tranche”) of its previously announced non-brokered private placement financing (the “Offering”). The Company issued 24,862,925 units (the “Units”) at a price of $0.05 per Unit for gross proceeds of $1,243,146.25. Please see the Company’s press release dated June 21, 2023 for further details regarding the Offering. Each Unit is comprised of one common share in the capital of the Company (each a “Common Share”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”). Each Warrant...

HESPERIA, Calif., July 14, 2023 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas (Fort Cady) Complex, announced today the Company’s plans to report fourth-quarter 2023 financial results after the market closes on Wednesday, August 30, 2023. The Company will host a live conference call and webcast to discuss the results and provide updates on key strategic initiatives, as well as project developments at 5:00 pm Central Time (CST). Interested parties can access the live webcast of the conference call on the Company’s website at https://5eadvancedmaterials.com/investors/events-and-presentations/. Dial-in information will also be provided ahead of time on the company website....

Financing sees meaningful insider participation and is incremental to $100 million received in May MUNICH, Germany, July 14, 2023 (GLOBE NEWSWIRE) — Lilium N.V. (Nasdaq: LILM) (“Lilium” or the “Company”), developer of the first all-electric vertical take-off and landing jet, announced a $192 million financing, including the pricing of an upsized $75 million underwritten public offering of 57,692,308 of the Company’s Class A ordinary shares (the “Shares”), as well as a concurrent $42 million private placement of 32,146,147 Shares and warrants to purchase 8,036,528 Shares led by Earlybird Venture Capital and including BIT Capital, UVC Partners, and Frank Thelen, as well as multiple Lilium board members and senior executives (the “PIPE”). Additionally, pursuant to the purchase agreement dated May 1, 2023, between the Company...

Siili Solutions Plc – Managers’ Transactions Siili Solutions Plc Stock Exchange Release 14 July 2023 at 14:15 EEST ____________________________________________Person subject to the notification requirement Name: Greater Fool OyPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Tomi PienimäkiPosition: Chief Executive OfficerIssuer: Siili Solutions OyjLEI: 7437003WYXJUSV27Q316Notification type: INITIAL NOTIFICATIONReference number: 35540/4/4____________________________________________Transaction date: 2023-07-13Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000043435Nature of transaction: ACQUISITION Transaction details(1): Volume: 495 Unit price: 13.4 EUR(2): Volume: 500 Unit price: 13.8 EUR(3): Volume: 5 Unit price: 13.95 EUR(4): Volume: 1000...

HOUSTON, July 14, 2023 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer will be participating in a fireside chat at the William Blair Innovator Series: Transitioning Biotech Breakthroughs to Commercial Success being held virtually on July 18, 2023.William Blair’s Innovator Series: Transitioning Biotech Breakthroughs to Commercial SuccessFormat: Fireside Chat with Aravive (ARAV)Date/Time: Tuesday, July 18, 2023 at 12:00-12:45 PM ETHost: Andy Hsieh, Ph.D., Biotech Research Analyst, William BlairPresenter: Gail McIntyre, Ph.D., DABT, CEO, AraviveWebcast: Conference attendees can check the schedule for more details...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 14, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced that it has received notifications from the Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department informing the Company that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5450(a)(1) and with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement for continued listing on the Nasdaq under Nasdaq Listing Rules 5450(b)(3)(C). As a result, CENTOGENE is now compliant with all applicable Nasdaq listing standards, and Nasdaq considers these matters closed. CENTOGENE was previously notified...

Senhance® Surgical System to be Exclusively Utilized within the Pediatric Surgery DepartmentThe Senhance Surgical System Leading United States-based hospital has initiated a Senhance Surgical System program for use within their pediatric surgery department.RESEARCH TRIANGLE PARK, N.C., July 14, 2023 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™(PGS), today announced that a leading United States-based hospital, has initiated a Senhance Surgical System program for use within their pediatric surgery department. The initiation of the Senhance program marks an important milestone as this represents the first system to be exclusively utilized by pediatric surgeons...